Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer
Phase 2
Terminated
- Conditions
- Stage IV Breast CancerBreast CancerRecurrent Breast Cancer
- Interventions
- Biological: panitumumabProcedure: laboratory biomarker analysisProcedure: immunohistochemistry staining method
- First Posted Date
- 2009-11-09
- Last Posted Date
- 2018-07-06
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 14
- Registration Number
- NCT01009983
- Locations
- 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
🇺🇸Ochsner Clinic Foundation, New Orleans, Louisiana, United States
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
Phase 4
Terminated
- Conditions
- Overactive BladderConstipationLower Urinary Tract Symptoms
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-10-28
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 12
- Registration Number
- NCT01003249
- Locations
- 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Nipple Sparing Mastectomy - Cosmetic Outcomes
Not Applicable
Completed
- Conditions
- Breast CancerBreast ReconstructionCosmesis
- Interventions
- Procedure: Nipple Sparing Mastectomy
- First Posted Date
- 2009-10-27
- Last Posted Date
- 2022-04-21
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 75
- Registration Number
- NCT01002014
- Locations
- 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States
Establishment of Cell Culture Systems From Discarded Operating Room Tissue
- Conditions
- Surgery
- First Posted Date
- 2009-10-22
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 1000
- Registration Number
- NCT01000077
- Locations
- 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer
Not Applicable
Withdrawn
- Conditions
- Stage III Prostate Cancer
- Interventions
- Dietary Supplement: omega-3 fatty acidOther: bone scanOther: dual x-ray absorptometryOther: laboratory biomarker analysisProcedure: biopsy
- First Posted Date
- 2009-10-16
- Last Posted Date
- 2018-07-03
- Lead Sponsor
- Wake Forest University Health Sciences
- Registration Number
- NCT00996749
Yoga or Educational Wellness Class for Women With Stage I, Stage II, or Stage III Breast Cancer Undergoing Chemotherapy
Not Applicable
Completed
- Conditions
- Breast CancerSleep DisordersFatigueDepression
- Interventions
- Behavioral: EducationBehavioral: Yoga
- First Posted Date
- 2009-10-14
- Last Posted Date
- 2021-10-20
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT00994279
- Locations
- 🇺🇸
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma
Not Applicable
Terminated
- Conditions
- Elbow Fracture
- Interventions
- Radiation: Radiation Therapy (XRT)
- First Posted Date
- 2009-10-08
- Last Posted Date
- 2022-04-21
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 48
- Registration Number
- NCT00991887
Effects of Aliskiren on Patient With Heart Failure and a Normal Ejection Fraction
- First Posted Date
- 2009-09-22
- Last Posted Date
- 2019-02-27
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 52
- Registration Number
- NCT00982033
- Locations
- 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
The Arthritis, Diet, and Activity Promotion Trial
Not Applicable
Completed
- Conditions
- Knee Osteoarthritis
- Interventions
- Behavioral: Dietary Weight-lossBehavioral: Exercise
- First Posted Date
- 2009-09-17
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 318
- Registration Number
- NCT00979043
- Locations
- 🇺🇸
Wake Forest University, Winston-Salem, North Carolina, United States
T-cell Depleted Alternative Donor Transplantation
Phase 2
Terminated
- Conditions
- Acute Myeloid LeukemiaChronic Myeloid LeukemiaBone Marrow FailureImmune DeficiencyHemoglobinopathyOsteopetrosisMyelodysplastic SyndromeAcute Lymphoblastic LeukemiaLymphomas
- Interventions
- Device: CliniMACS® (T cell depletion)
- First Posted Date
- 2009-08-31
- Last Posted Date
- 2022-04-22
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 53
- Registration Number
- NCT00968864
- Locations
- 🇺🇸
Levine Children's Hospital, Carolinas Medical Center, Charlotte, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath